XRAY · NASDAQ · STOCK
Dentsply Sirona (XRAY) Stock Analysis
$11.38
52W $9.41 – $14.76
54/100
$2.28B
-4.2
0.85
Is XRAY Bullish or Bearish?
Mixed.
Innellis AI committee rates Dentsply Sirona (XRAY) Watch with a composite score of 54/100
, based on 6 analysts with 33% agreement.
Last updated September 06, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +6.22 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -13.78 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — high leverage (debt-to-equity 1.74) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Dividend yield of 5.5% pays you to wait — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- News sentiment is positive (+0.38 across 8 articles, 14d) — News
Bear Case
- ROE of only -39.8% -- cheap may mean cheap for a reason — Value
- Debt-to-equity of 1.74 adds balance-sheet risk to the value case — Value
- Revenue declining -0.8% YoY -- this is not a growth story right now — Growth
- Price structure making lower highs and lower lows — Technical
- Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
- High leverage (debt-to-equity 1.74) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 06, 2026
Overall Committee Score
54/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 89%
of 192 Healthcare peers
Value Analyst
bearish
40
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
+ Dividend yield of 5.5% pays you to wait
− ROE of only -39.8% -- cheap may mean cheap for a reason
Growth Analyst
neutral
50
/ 100 · Moderate confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -0.8% YoY -- this is not a growth story right now
Technical Analyst
neutral
53
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst
bearish
30
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.74) amplifies downside in a stress scenario
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
70
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.38 across 8 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2704.43)
Investment Thesis Evolution
Committee score moved marginally from 53.8 to 53.8.
Comparing 2026-09-05 to 2026-09-06 (1 day apart).
Technical Analysis
RSI (14)
53.7
Neutral
MACD Histogram
0.066
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Hh Hl
Support
$10.86
Resistance
$13.01
Bollinger %B
0.67
Inside Bands
Price vs Moving Averages
EMA 9
$11.22
Above
EMA 21
$11.45
Below
EMA 50
$11.69
Below
EMA 200
$12.19
Below
Fundamental Analysis
Valuation
99
Growth
72
Profitability
18
Financial Health
54
Cash Flow
70
Valuation
P/E Ratio
-4.2×
P/B Ratio
1.68×
PEG Ratio
-0.08
Dividend Yield
2.81%
52W High
$14.76
52W Low
$9.41
Quality & Growth
ROE
-4462.7%
ROA
-1101.5%
Gross Margin
4952.0%
Operating Margin
1169.4%
Revenue Growth YoY
—
Debt / Equity
1.71
AI Fundamental Assessment
P/E ratio of -4.2 (inexpensive relative to a 15-40x range); Price-to-book of 1.7x; PEG ratio of -0.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -44.6%; Return on assets of -11.0%; Net margin of -15.0%; Gross margin of 49.5%; Current ratio of 1.63 (healthy short-term liquidity); Debt-to-equity of 1.71; Free cash flow per share is positive (0.72); Most recent quarter beat estimates by 46.1%; EPS growth accelerating (+0.0% -> +92.6% QoQ); Average YoY EPS growth of 0.0%; Analyst estimates rising over recent quarters
Get the Full XRAY Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →